Cost-effectiveness of treatment for chronic hepatitis C infection.
Bernstein
David
D
D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D011788:Quality of Life
D000998:Antiviral Agents